CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.806
EU - Europa 4.090
AS - Asia 3.055
SA - Sud America 519
AF - Africa 206
Continente sconosciuto - Info sul continente non disponibili 154
OC - Oceania 48
Totale 12.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.651
RU - Federazione Russa 1.751
SG - Singapore 1.369
IT - Italia 970
CN - Cina 507
BR - Brasile 405
HK - Hong Kong 299
VN - Vietnam 269
DE - Germania 244
GB - Regno Unito 233
IE - Irlanda 160
FI - Finlandia 145
SE - Svezia 137
FR - Francia 115
KR - Corea 97
BD - Bangladesh 94
IN - India 80
NL - Olanda 79
CA - Canada 75
ID - Indonesia 69
TR - Turchia 59
ES - Italia 58
TG - Togo 47
MX - Messico 44
NG - Nigeria 44
JP - Giappone 43
AU - Australia 42
BJ - Benin 40
PL - Polonia 36
AR - Argentina 34
AT - Austria 27
ZA - Sudafrica 27
IQ - Iraq 21
CH - Svizzera 19
EC - Ecuador 19
MY - Malesia 19
SA - Arabia Saudita 18
IR - Iran 17
CL - Cile 15
CO - Colombia 15
UA - Ucraina 15
PH - Filippine 14
PK - Pakistan 12
BE - Belgio 10
DK - Danimarca 10
HR - Croazia 10
VE - Venezuela 10
AL - Albania 9
EG - Egitto 9
UZ - Uzbekistan 9
DZ - Algeria 8
RO - Romania 8
TN - Tunisia 8
JO - Giordania 7
MA - Marocco 7
NP - Nepal 7
PT - Portogallo 7
UY - Uruguay 7
GR - Grecia 6
JM - Giamaica 6
AZ - Azerbaigian 5
HU - Ungheria 5
IL - Israele 5
IS - Islanda 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
BG - Bulgaria 4
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
ET - Etiopia 4
GD - Grenada 4
GT - Guatemala 4
HN - Honduras 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
EE - Estonia 3
GE - Georgia 3
GH - Ghana 3
LB - Libano 3
LT - Lituania 3
NO - Norvegia 3
AO - Angola 2
BN - Brunei Darussalam 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
AD - Andorra 1
Totale 12.704
Salva come PNG Salva come JPEG
Città #
Singapore 728
Ashburn 719
San Jose 644
Moscow 629
Dallas 581
Hong Kong 284
Council Bluffs 270
Chandler 267
Verona 189
Dublin 149
The Dalles 121
New York 120
Munich 114
Ho Chi Minh City 103
Beijing 102
Los Angeles 99
Milan 85
Helsinki 77
London 66
Hanoi 65
Rome 61
Santa Clara 60
Jakarta 51
Lappeenranta 51
Lomé 47
Buffalo 42
Cotonou 40
Houston 40
Naples 39
Phoenix 39
Chicago 37
Southend 37
Redondo Beach 36
São Paulo 36
Abuja 33
Lawrence 33
Princeton 33
Washington 30
Bologna 29
Jacksonville 29
Amsterdam 28
Atlanta 28
McKinney 28
Tokyo 28
Seattle 27
Warsaw 27
Wilmington 25
Frankfurt am Main 24
Orem 24
Sindelfingen 24
Annandale 23
Chennai 23
Brooklyn 21
Nuremberg 21
Venice 20
Mexico City 19
Montreal 18
Toronto 18
Turin 18
Florence 17
Istanbul 17
Sydney 17
Cleveland 16
Madrid 16
Kuala Lumpur 15
Boston 14
Denver 14
Johannesburg 14
Shanghai 14
Brasília 13
Mumbai 13
Tianjin 13
Xi'an 13
Barcelona 12
Enfield 12
Guangzhou 12
Rio de Janeiro 12
Belo Horizonte 11
Columbus 11
Haiphong 11
Manchester 11
North Hollywood 11
Vienna 11
Baghdad 10
Palermo 10
Perth 10
Trieste 10
Zurich 10
Brescia 9
Copenhagen 9
Da Nang 9
Dongguan 9
Esslingen am Neckar 9
Genoa 9
Las Vegas 9
Santiago 9
Tashkent 9
Boardman 8
Brussels 8
Mersin 8
Totale 7.134
Salva come PNG Salva come JPEG
Nome #
Il ruolo della vitamina D nella dermatite atopica 454
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 379
A systematic review of treatments for pityriasis lichenoides 350
Dietary supplements for lipedema 333
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 269
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 196
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 181
Polymorphisms, diet and nutrigenomics 178
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 178
Main nutritional deficiencies 168
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 168
Impact of the COVID-19 pandemic on melanoma diagnosis 165
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 162
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 161
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 161
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 160
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 141
Dermoscopic features of nevoid melanoma: a retrospective study 138
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 138
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 138
Amicrobial Pustulosis of the Folds: Report of Three New Cases 138
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 138
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 136
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 135
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review 133
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 133
Adrenergic urticaria successfully treated with omalizumab 133
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 131
Coexistence of scleromyxedema and Sneddon syndrome 130
Clinical profile and co-infections of urethritis in males 129
Price variability of TNF-α inhibitor biosimilars among European countries 129
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 128
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 126
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells 124
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 124
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 120
The transition from mild to moderate-to-severe chronic plaque psoriasis 120
Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics 118
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 118
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 118
Managing the Patient with Psoriasis and Metabolic Comorbidities 117
Sezary syndrome with large cell transformation and T-follicular helper phenotype 117
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 111
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 111
Upadacitinib in refractory cutaneous pseudolymphoma: A case report 111
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 110
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 110
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 109
Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report 107
Awareness of obesity among patients with psoriasis 107
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 105
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 105
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 104
Predictors of subsequent primary melanoma: a case-control study 103
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 100
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 100
Dupilumab for recalcitrant Kimura disease 100
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 98
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 98
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 98
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 96
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 95
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 94
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 94
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience 93
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 93
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the “Save Your Skin” Screening Campaign 92
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 92
Generalized pustular psoriasis successfully treated with spesolimab: A case report 91
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 91
Dietary supplements for the management of COVID-19 symptoms 89
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 88
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 88
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 88
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 84
Polyphenols and Lactobacillus reuteri in oral health 83
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 83
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 83
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 81
Monkeypox virus infection: what dermatologist needs to know? 80
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 78
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 77
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 76
Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis 75
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 74
X-linked genodermatoses from diagnosis to tailored therapy 72
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 69
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 68
Neurothekeoma: a pediatric case report and literature review 68
Long-term follow-up of Zoon balanitis: a retrospective cohort study 66
Omics sciences and precision medicine in melanoma 65
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 63
Super Responder Profle Under Bimekizumab Treatment in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life Observation—IL PSO (Italian Landscape Psoriasis) 62
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 62
Psoriasis: talking points from recent clinical trials 62
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 62
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 61
Corymbose Syphilis 60
Bluish-Green Coloration of the Nipples: A Diagnostic Clue for Retroareolar Cysts 57
Scurvy as Presenting Sign of Anorexia Nervosa 57
Totale 12.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.241
article - articoli 51.241
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022177 0 0 0 12 30 11 15 16 11 12 16 54
2022/20231.117 37 71 60 143 63 200 15 53 210 157 78 30
2023/2024932 59 64 96 101 82 165 66 56 16 42 108 77
2024/20252.458 118 103 124 376 116 145 227 112 373 191 166 407
2025/20266.713 420 476 438 865 1.720 376 678 465 467 390 162 256
2026/20271.307 323 194 307 483 0 0 0 0 0 0 0 0
Totale 12.878